Podcasts about agerelated

John Tower is a professor of biology and gerontology. He spoke to us about his research on the roles of sex differences and mitochondria in aging. Highlights from our conversation: As you may know, in humans, women live longer than men. And the reason for that is not entirely understood and also malfunction of the mitochondria, which is also called the powerhouse of the cell is, directly implicated in aging and multiple aging-related diseases, including Parkinson's disease and Alzheimer's disease and cancer. And so we'd like to understand at a very basic level, why does the mitochondria malfunction during aging and does this, or does this not have, uh, is this related to, or a result of sexual differentiation of the male and female?   While there's no consensus in the aging field on pretty much anything. But, I would say at this point, antagonistic pleiotropy is the most favored model for how the genetics of aging works across species. And the idea is that genes can be beneficial in one context, but detrimental in another context. Specifically they're likely to be beneficial early in life, promoting things like differentiation and growth and sexual reproduction and in the long term, the same genes are detrimental and have a cost during aging. I've made a complete about face, from thinking that sexual differentiation was not important, to thinking that well, maybe sexual differentiation is actually causative to a large part in the aging process. In other words, in differentiating the male and the female, you set up the situation for sex specific trade-offs between reproduction and aging, and some aspects of these trade-offs are common between the male and the female. And some of them are unique to either the male or the female in that there are pathways that promote a reproduction, but then have a cost for the long-term maintenance of the animal. That's the kind of antagonistic pleiotropy my lab is focusing on right now which is the idea that a gene can be beneficial to one sex, but detrimental to the other, or a gene could be detrimental to each sex in different ways   Across species, we see a decrease in mitochondrial gene expression and mitochondrial gene function during aging and the relevance to sex is that the mitochondria is transmitted to offspring only through the mother. And so this means natural selection can only optimize mitochondrial gene function for the female. This means that the male inherits a mitochondria that is less optimal for his physiology than, than it might be. And so what we see is that mitochondria isolated from female mammal tissues function better than mitochondria isolated from males consistent with this hypothesis. And so this may be one reason why females tend to live longer than males I think what I would expect is we're going to see sex-specific interventions in aging and aging-related diseases,  even diseases common to the male and the female, like Parkinson's and Alzheimer's,  that having an intervention that's tailored, to the male or the female will be more efficacious.  

Low vision affects approximately 2.9 million Americans age 40 and older. This month's guest is researcher Bonnielin Swenor, an assistant professor of ophthalmology at the Wilmer Eye Institute and an assistant professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health discusses her personal experience and research that focuses on the impact of  and eye disease such as age-related macular degeneration, on aging. She also shares her personal connection to her research.

In this MedEdTalks micro-CE podcast, Rishi P. Singh, MD, and Dilsher S. Dhoot, MD, discuss current barriers to care of patients with neovascular age-related macular degeneration (AMD) and other management considerations for providers.  Transcript: https://bit.ly/2RL41uX To obtain CME Credit, please go here: https://bit.ly/2mJfo9s

Robert Rountree, MD, joins Integrative Practitioner editor, Katherine Rushlau, to discuss the pervasive pathological processes involved in senescence and how these processes can lead to aged-related disease.

Should older patients with lung cancer undergo surgery? What issues affect the probability of an elderly patients safely undergoing lung cancer surgery. Dr. Eric Vallières, thoracic surgeon, provides an expert perspective.

Should older patients with lung cancer undergo surgery? What issues affect the probability of an elderly patients safely undergoing lung cancer surgery. Dr. Eric Vallières, thoracic surgeon, provides an expert perspective.

Should older patients with lung cancer undergo surgery? What issues affect the probability of an elderly patients safely undergoing lung cancer surgery. Dr. Eric Vallières, thoracic surgeon, provides an expert perspective.